Suppr超能文献

通咽喷雾剂对缺血性脑卒中后吞咽障碍患者舌骨运动的影响及安全性。

Effect and Safety of Tongyan Spray () on Hyoid Motion in Patients with Dysphagia after Ischemic Stroke.

机构信息

Department of Encephalopathy, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, 100039, China.

Department of Neurology, China Rehabilitation Research Center, Beijing, 100068, China.

出版信息

Chin J Integr Med. 2021 May;27(5):369-374. doi: 10.1007/s11655-020-3325-y. Epub 2020 Sep 30.

Abstract

OBJECTIVE

To observe the effects and safety of Tongyan Spray () on the range and time of hyoid motion in patients with ischemic post-stroke dysphagia.

METHODS

Seventy-two patients with ischemic post-stroke dysphagia were selected and randomly assigned to a treatment group (36 cases) and a control group (36 cases) by a random number table from January 2013 to October 2014. All patients swallowed 4 kinds of barium meals with different traits respectively, and each patient underwent video fluoroscopy (VF) examination twice. In the treatment group, Tongyan Spray was sprayed to the pharynx on both sides and the middle part once respectively. The spray was applied 30 min before the second examination. Purified water at room temperature was used as placebo in the control group. The changes in the range and time of hyoid motion in both groups were observed before and after treatment.

RESULTS

Six patients dropped out in each group, and 60 patients completed the study and were included in the final analysis. Significant improvement was observed in the range of superior hyoid excursion distance and the time of hyoid motion in the treatment group compared with the control group (P<0.05). There were no obvious adverse reactions observed in oral mucosa in both groups during the whole study.

CONCLUSION

Tongyan Spray was an effective and safe medicine for improving swallowing function in patients with ischemic post-stroke dysphagia.

摘要

目的

观察通咽喷雾剂对缺血性脑卒中后吞咽障碍患者舌骨运动幅度和时间的影响。

方法

选取 2013 年 1 月至 2014 年 10 月收治的缺血性脑卒中后吞咽障碍患者 72 例,采用随机数字表法将患者分为治疗组和对照组,各 36 例。所有患者分别吞咽 4 种不同性状的钡餐,且每位患者均行两次视频透视(VF)检查。治疗组于第二次检查前 30 min 向双侧咽及中部各喷通咽喷雾剂 1 次,对照组给予室温下的纯净水作为安慰剂。观察治疗前后两组患者舌骨运动幅度和时间的变化。

结果

每组各脱落 6 例患者,最终 60 例患者完成研究并纳入最终分析。与对照组比较,治疗组患者的舌骨上抬距离和舌骨运动时间明显改善(P<0.05)。两组患者在整个研究过程中口腔黏膜均未见明显不良反应。

结论

通咽喷雾剂是治疗缺血性脑卒中后吞咽障碍的有效、安全药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验